Viewing Study NCT00453128



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00453128
Status: COMPLETED
Last Update Posted: 2007-03-28
First Post: 2007-03-26

Brief Title: Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients
Sponsor: Sociedade Galega de Reumatoloxía
Organization: Sociedade Galega de Reumatoloxía

Study Overview

Official Title: Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease
Status: COMPLETED
Status Verified Date: 2007-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease
Detailed Description: The diagnostic usefulness of screening for hyperparathyroidism hemochromatosis hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate CPPD deposition disease is uncertain

Patients diagnosed with CPPD deposition disease were compared to patients with rheumatoid arthritis and psoriatic arthritis over a 9-year period All patients were prospectively followed for at least 12 months Serum calcium phosphorus alkaline phosphatase thyroid-stimulating hormone ferritin iron and total iron binding capacity were determined in all patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None